Literature DB >> 6696190

Comparison of Schistosoma mansoni migration patterns in normal and irradiated cercaria-immunized mice by means of autoradiographic analysis. Evidence that worm elimination occurs after the skin phase in immunized mice.

D A Dean, B L Mangold, J R Georgi, R H Jacobson.   

Abstract

Migration and elimination of radiolabeled Schistosoma mansoni were compared in naive and irradiated cercaria-immunized mice by autoradiography of compressed host tissues. The results indicated that 1) most of the normal elimination of schistosomula in unimmunized mice and the additional elimination in immunized mice occur at some point(s) after arrival of schistosomula in the lungs and before their development into adult worms, 2) migration of schistosomula from skin to lungs is delayed for several days but not reduced in immunized mice, 3) migration of schistosomula from lungs to liver is delayed for several days in immunized mice, and 4) schistosomula reach the liver in reduced numbers or are killed and cleared in the liver in greater numbers in immunized mice. The lung chop procedure was shown to recover schistosomula from control and irradiated cercaria-immunized mice with equal efficiency. Autoradiography of all tissues of the body demonstrated that, in both control and immunized mice, at least 20-25% of the schistosomula detectable 2 and 3 weeks after infection were present in tissues other than the skin, lungs and liver.

Entities:  

Mesh:

Year:  1984        PMID: 6696190     DOI: 10.4269/ajtmh.1984.33.89

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  14 in total

1.  Schistosoma mansoni larvicidal activity of murine bronchoalveolar lavage cells.

Authors:  F A Lewis; C A White-Ziegler; J E Ball; G M Niemann
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

2.  Developmental differences determine larval susceptibility to nitric oxide-mediated killing in a murine model of vaccination against Schistosoma mansoni.

Authors:  S F Ahmed; I P Oswald; P Caspar; S Hieny; L Keefer; A Sher; S L James
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

3.  Macrophage activation as an immune correlate to protective immunity against schistosomiasis in mice immunized with an irradiated, cryopreserved live vaccine.

Authors:  F A Lewis; J Winestock; S L James
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

4.  Nucleic acid vaccination with Schistosoma mansoni antioxidant enzyme cytosolic superoxide dismutase and the structural protein filamin confers protection against the adult worm stage.

Authors:  Rosemary M Cook; Claudia Carvalho-Queiroz; Gregory Wilding; Philip T LoVerde
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

5.  Chronic intestinal nematode infection exacerbates experimental Schistosoma mansoni infection.

Authors:  Quentin D Bickle; Julie Solum; Helena Helmby
Journal:  Infect Immun       Date:  2008-09-29       Impact factor: 3.441

6.  Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen.

Authors:  E J Pearce; S L James; S Hieny; D E Lanar; A Sher
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

7.  Cercarial glycocalyx of Schistosoma mansoni activates human complement.

Authors:  J C Samuelson; J P Caulfield
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

8.  Limitations to schistosome growth and maturation in nonpermissive hosts.

Authors:  D Cioli; L Pica-Mattoccia; P M Knopf
Journal:  J Chem Ecol       Date:  1986-08       Impact factor: 2.626

9.  Comparison of the role of complement in immunity to Schistosoma mansoni in rats and mice.

Authors:  D A Vignali; Q D Bickle; M G Taylor; G Tennent; M B Pepys
Journal:  Immunology       Date:  1988-01       Impact factor: 7.397

10.  Cytokine and eicosanoid regulation by Schistosoma mansoniduring LSE penetration.

Authors:  A C Fusco; B Salafsky; T Shibuya
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.